AstraZeneca requests emergency authorization for coronavirus drug cocktail
An Anglo-Swedish pharmaceutical company wants regulatory approval for new medication that could dramatically help COVID-19 patients reduce the risk of developing symptoms. AstraZeneca is asking the U.S. Food and Drug Administration (FDA) and foreign governments to authorize emergency use for its AZD7442 antibody cocktail. The first protective injection against the virus ...
End of content
No more pages to load